Preclinical Software for Physiology Data Assessment and Animal Supervision Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, UK, Germany, France, Japan - Size and Forecast 2024-2028

Published: Jan 2024 Pages: 161 SKU: IRTNTR45008

Preclinical Software for Physiology Data Assessment and Animal Supervision Market 2024-2028

The Preclinical Software for Physiology Data Assessment and Animal Supervision Market size is forecast to increase by USD 3.92 billion, at a CAGR of 5.62% between 2023 and 2028. 

There has been an increasing awareness of physiological monitoring in preclinical research across the globe. In addition, in preclinical research, laboratory animals are considered a valuable resource. Moreover, the use of small animal subjects, such as rats and mice, as surgical models for biomedical research involves a substantial financial investment as well as time. Furthermore, scientists who have adequate resources to work with animal subjects have to accept the responsibility for ethical considerations. In addition, it is important to undertake all possible measures for achieving the maximum success rate with proper accuracy while simultaneously ensuring the safety and welfare of these animal subjects. Hence, such factors are positively impacting the market growth.

Technavio has segmented the market into End-user, Deployment, and Geography

  • The end-user segment is classified into industrial labs and CROs and academic, government, and research labs
  • The  deployment segment is classified into on-premises and cloud
  • The geography segment includes key regions such as North America, Europe, Asia, and the Rest of the World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2018 - 2022, besides analyzing the current market scenario.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Download Report Sample

Segmentation by End-user, Deployment, and Geography Analysis

End-user Analysis 

Industrial labs and CROs

The industrial labs and CROs segment is estimated to witness significant growth during the forecast period. Several pharmaceutical and biotechnology companies have developed the infrastructure needed to conduct preclinical and clinical studies for testing their drug candidates. However, various companies also outsource their preclinical research requirements to CROs to gain cost savings as well as to get access to a broad range of equipment and laboratory facilities, including preclinical software.

Get a glance at the market contribution of various segments Download PDF Sample

The industrial labs and CROs segment was the largest segment and was valued at USD 6.50 billion in 2018. Moreover, CROs can perform research activities that range from basic research to late-stage development, including R&D tasks, such as genetic engineering, safety and efficacy testing in animal models, hit exploration and lead optimization, assay development, target validation, as well as clinical trials involving people. In addition,  biopharmaceutical companies have also increased their dependence on CROs for services in areas of preclinical and clinical research and drug discovery due to the high pressure that they face for improved R&D productivity. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

Deployment Analysis 

On-premises

The on-premises deployment model offers a localized and secure solution for research facilities. In addition, in this model, the software is installed and operates within the organization's own computing infrastructure. For instance, ADInstruments Pty Ltd. provides a suite of software solutions, including LabChart, that enables researchers to collect and analyze physiological data in real time. Furthermore, the on-premises model ensures data security, compliance with regulatory standards, and customization based on the specific needs of research institutions and laboratories. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

Cloud

The cloud deployment model comprises hosting software solutions on external servers managed by third-party software providers. In addition, the cloud operates over the internet, enabling users to access applications remotely without the need for on-premises infrastructure. Moreover, this model facilitates collaborative research efforts, as data can be securely stored and accessed from various locations, streamlining real-time collaboration and analysis of physiological data.  Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 44% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The leading position of North America in biomedical research and technological innovation is a primary catalyst, with prominent research institutions, academic centers, and pharmaceutical companies demanding advanced software solutions. In addition, government initiatives, particularly substantial funding from agencies such as the National Institutes of Health (NIH), contribute significantly, enabling the adoption of cutting-edge preclinical software technologies. Moreover, North America's stringent regulatory environment emphasizes the need for sophisticated software tools to ensure compliance and data integrity in preclinical studies. In addition, in North America, a significant number of people suffer from chronic diseases, such as cancer, asthma, COPD, and Alzheimer's disease, among others.  Therefore, this has led to a substantial demand for scientific research as well as drug discovery and development, which, in turn, has resulted in a rapid rise in R&D expenditure on related research. Hence, such factors are driving market growth in North America during the forecast period.

Buy Full Report Now

Key Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 19 market companies, including:

ADInstruments Pty Ltd: The company offers preclinical software for physiology data assessment and animal supervision such as LabChart and LabChart Lightning for physiological, biological, and biomedical research.

  • BIOPAC Systems Inc.
  • Bruker Corp.
  • Columbus Instruments LLC
  • emka TECHNOLOGIES
  • ETISENSE SAS
  • Harvard Bioscience Inc.
  • Instem Plc
  • Med Associates Inc.
  • Noldus Information Technology bv
  • PerkinElmer Inc
  • Starr Life Sciences Corp.
  • Stoelting Co.
  • Thermo Fisher Scientific Inc.
  • TSE Systems GmbH
  • UGO BASILE S.R.L.
  • Vanderbilt University Medical Center
  • Xybion Digital Inc.
  • Zaber Technologies Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Key Drivers

One of the key factors driving the market growth is the emerging role of bioinformatics tools and software in preclinical research. Bioinformatics tools and software play a major role in the development of drug development as well as drug discovery. In addition, in these applications, the research requires bioinformatics tools for several reasons, including for using preclinical data in secondary research, for managing data during clinical trials, and for expanding knowledge related to human disease and overall health.

Moreover, the emergence of novel technologies in areas such as proteomics, molecular dynamics simulation, molecular docking, and quantitative structure-activity relationships in clinical research facilitates and speeds up the drug discovery procedure. Furthermore, during the preclinical research stage, this software is extensively used for randomization in planning the study design and eliminating any bias. Hence, such factors are driving the market growth during the forecast period.

Significant Trends

A key factor shaping the market growth is the rising digitalization in preclinical research. Preclinical research has become a crucial part of drug development and scientific research. However, taking manual readings may result in highly inaccurate results that might negatively impact the outcome of experiments. Therefore, the market is witnessing the advent of digitization in preclinical research.

Moreover, one of the major breakthroughs has been the ability to capture preclinical data electronically. In addition, for many years, companies worldwide have extensively used electronic data capture for data collection in clinical research settings. Furthermore, many software companies are developing tools that enable researchers and scientists to gather data electronically in preclinical studies. Hence, such factors are positively impacting the market which in turn drives the market growth during the forecast period.

Major  Challenges

Characteristic disadvantages of animal studies are one of the key challenges hindering market growth. Although animal subjects are considered useful and are extensively used in preclinical research, there are many characteristic disadvantages of animal studies.  For instance, one of the major disadvantages that scientists face during preclinical research is the inability to replicate animal studies in human trials. 

Moreover, this can be attributed to the poor design of the procedures in experiments, the choice of incorrect approaches while conducting the procedures in the lab environment, or the inaccurate analysis of the measurements. In addition, the small size of mice leads to challenges such as the lack of precision in assessing the mechanical response of the organs, due to which scientists have to compromise on the non-invasiveness of the experiment. Hence, such factors are hindering the market growth during the forecast period.

Buy Now Full Report

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

 Customer Landscape

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides a market research and growth analysis of the latest market trends and analysis and growth opportunities from 2018 to 2028. 

  • End-user Outlook
    • Industrial labs and CROs
    • Academic, government, and research labs
  • Deployment Outlook
    • On-premises
    • Cloud
  • Geography Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of the World (ROW)
      • Australia
      • Argentina
      • Brazil

Preclinical Software for Physiology Data Assessment and Animal Supervision Market Scope

Report Coverage

Details

Page number

161

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 5.62%

Market Growth 2024-2028

USD 3.92 billion

Market structure

Fragmented

YoY growth 2023-2024(%)

4.89

Regional analysis

North America, Europe, Asia, and the Rest of the World (ROW)

Performing market contribution

North America at 44%

Key countries

US, UK, Germany, France, and Japan

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

ADInstruments Pty Ltd., BIOPAC Systems Inc., Bruker Corp., Columbus Instruments LLC, emka TECHNOLOGIES, ETISENSE SAS, Harvard Bioscience Inc., Instem Plc, Med Associates Inc., Noldus Information Technology bv, PerkinElmer Inc, Starr Life Sciences Corp., Stoelting Co., Thermo Fisher Scientific Inc., TSE Systems GmbH, UGO BASILE S.R.L., Vanderbilt University Medical Center, Xybion Digital Inc., and Zaber Technologies Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Preclinical Software for Physiology Data Assessment and Animal Supervision Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of between 2023 and 2028
  • Precise estimation of the size and its contribution to the market in focus on the parent market
  • Detailed market growth analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies position and classification
  • Accurate market forecast about upcoming market growth and trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and the Rest of the World (ROW)
  • Thorough market growth and forecasting analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive market analysis and report of factors that will challenge the growth of companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Deployment
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global preclinical software for physiology data assessment and animal supervision market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global preclinical software for physiology data assessment and animal supervision market 2018 - 2022 ($ billion)
    • 4.2 End-user Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – End-user Segment 2018 - 2022 ($ billion)
    • 4.3 Deployment Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – Deployment Segment 2018 - 2022 ($ billion)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by End-user

    • 6.1 Market segments
      • Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
    • 6.2 Comparison by End-user
      • Exhibit 32: Chart on Comparison by End-user
      • Exhibit 33: Data Table on Comparison by End-user
    • 6.3 Industrial labs and CROs - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Industrial labs and CROs - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 35: Data Table on Industrial labs and CROs - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 36: Chart on Industrial labs and CROs - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Industrial labs and CROs - Year-over-year growth 2023-2028 (%)
    • 6.4 Academic, government, and research labs - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Academic, government, and research labs - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 39: Data Table on Academic, government, and research labs - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 40: Chart on Academic, government, and research labs - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Academic, government, and research labs - Year-over-year growth 2023-2028 (%)
    • 6.5 Market opportunity by End-user
      • Exhibit 42: Market opportunity by End-user ($ billion)
      • Exhibit 43: Data Table on Market opportunity by End-user ($ billion)

    7 Market Segmentation by Deployment

    • 7.1 Market segments
      • Exhibit 44: Chart on Deployment - Market share 2023-2028 (%)
      • Exhibit 45: Data Table on Deployment - Market share 2023-2028 (%)
    • 7.2 Comparison by Deployment
      • Exhibit 46: Chart on Comparison by Deployment
      • Exhibit 47: Data Table on Comparison by Deployment
    • 7.3 On-premises - Market size and forecast 2023-2028
      • Exhibit 48: Chart on On-premises - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 49: Data Table on On-premises - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 50: Chart on On-premises - Year-over-year growth 2023-2028 (%)
      • Exhibit 51: Data Table on On-premises - Year-over-year growth 2023-2028 (%)
    • 7.4 Cloud - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Cloud - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 53: Data Table on Cloud - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 54: Chart on Cloud - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Cloud - Year-over-year growth 2023-2028 (%)
    • 7.5 Market opportunity by Deployment
      • Exhibit 56: Market opportunity by Deployment ($ billion)
      • Exhibit 57: Data Table on Market opportunity by Deployment ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 59: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 60: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 61: Chart on Geographic comparison
      • Exhibit 62: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 UK - Market size and forecast 2023-2028
      • Exhibit 83: Chart on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 84: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 85: Chart on UK - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.9 Germany - Market size and forecast 2023-2028
      • Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.10 France - Market size and forecast 2023-2028
      • Exhibit 91: Chart on France - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 92: Data Table on France - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 93: Chart on France - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on France - Year-over-year growth 2023-2028 (%)
    • 9.11 Japan - Market size and forecast 2023-2028
      • Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 99: Market opportunity by geography ($ billion)
      • Exhibit 100: Data Tables on Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 101: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 103: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 104: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 105: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 106: Matrix on vendor position and classification
            • 12.3 ADInstruments Pty Ltd.
              • Exhibit 107: ADInstruments Pty Ltd. - Overview
              • Exhibit 108: ADInstruments Pty Ltd. - Product / Service
              • Exhibit 109: ADInstruments Pty Ltd. - Key offerings
            • 12.4 BIOPAC Systems Inc.
              • Exhibit 110: BIOPAC Systems Inc. - Overview
              • Exhibit 111: BIOPAC Systems Inc. - Product / Service
              • Exhibit 112: BIOPAC Systems Inc. - Key offerings
            • 12.5 Bruker Corp.
              • Exhibit 113: Bruker Corp. - Overview
              • Exhibit 114: Bruker Corp. - Business segments
              • Exhibit 115: Bruker Corp. - Key offerings
              • Exhibit 116: Bruker Corp. - Segment focus
            • 12.6 Columbus Instruments LLC
              • Exhibit 117: Columbus Instruments LLC - Overview
              • Exhibit 118: Columbus Instruments LLC - Product / Service
              • Exhibit 119: Columbus Instruments LLC - Key offerings
            • 12.7 emka TECHNOLOGIES
              • Exhibit 120: emka TECHNOLOGIES - Overview
              • Exhibit 121: emka TECHNOLOGIES - Product / Service
              • Exhibit 122: emka TECHNOLOGIES - Key offerings
            • 12.8 ETISENSE SAS
              • Exhibit 123: ETISENSE SAS - Overview
              • Exhibit 124: ETISENSE SAS - Product / Service
              • Exhibit 125: ETISENSE SAS - Key offerings
            • 12.9 Harvard Bioscience Inc.
              • Exhibit 126: Harvard Bioscience Inc. - Overview
              • Exhibit 127: Harvard Bioscience Inc. - Product / Service
              • Exhibit 128: Harvard Bioscience Inc. - Key offerings
            • 12.10 Instem Plc
              • Exhibit 129: Instem Plc - Overview
              • Exhibit 130: Instem Plc - Product / Service
              • Exhibit 131: Instem Plc - Key offerings
            • 12.11 Med Associates Inc.
              • Exhibit 132: Med Associates Inc. - Overview
              • Exhibit 133: Med Associates Inc. - Product / Service
              • Exhibit 134: Med Associates Inc. - Key offerings
            • 12.12 Noldus Information Technology bv
              • Exhibit 135: Noldus Information Technology bv - Overview
              • Exhibit 136: Noldus Information Technology bv - Product / Service
              • Exhibit 137: Noldus Information Technology bv - Key offerings
            • 12.13 PerkinElmer Inc
              • Exhibit 138: PerkinElmer Inc - Overview
              • Exhibit 139: PerkinElmer Inc - Business segments
              • Exhibit 140: PerkinElmer Inc - Key news
              • Exhibit 141: PerkinElmer Inc - Key offerings
              • Exhibit 142: PerkinElmer Inc - Segment focus
            • 12.14 Starr Life Sciences Corp.
              • Exhibit 143: Starr Life Sciences Corp. - Overview
              • Exhibit 144: Starr Life Sciences Corp. - Product / Service
              • Exhibit 145: Starr Life Sciences Corp. - Key offerings
            • 12.15 Stoelting Co.
              • Exhibit 146: Stoelting Co. - Overview
              • Exhibit 147: Stoelting Co. - Product / Service
              • Exhibit 148: Stoelting Co. - Key offerings
            • 12.16 TSE Systems GmbH
              • Exhibit 149: TSE Systems GmbH - Overview
              • Exhibit 150: TSE Systems GmbH - Product / Service
              • Exhibit 151: TSE Systems GmbH - Key offerings
            • 12.17 Xybion Digital Inc.
              • Exhibit 152: Xybion Digital Inc. - Overview
              • Exhibit 153: Xybion Digital Inc. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 154: Inclusions checklist
                • Exhibit 155: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 156: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 157: Research methodology
                • Exhibit 158: Validation techniques employed for market sizing
                • Exhibit 159: Information sources
              • 13.5 List of abbreviations
                • Exhibit 160: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              preclinical software for physiology data assessment and animal supervision market market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis